tiprankstipranks
Advertisement
Advertisement

EBOS Updates Market on Lapse of Performance Rights

Story Highlights
  • EBOS Group operates as a major trans-Tasman healthcare products and services provider.
  • EBOS reported the lapse of 5,116 performance rights, leaving 1,429,417 rights outstanding and slightly adjusting potential shareholder dilution.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EBOS Updates Market on Lapse of Performance Rights

Claim 55% Off TipRanks

EBOS Group Limited ( (NZ:EBO) ) has provided an update.

EBOS Group Limited has announced that 5,116 performance rights have lapsed under its equity arrangements for employees or executives. As a result of this change, the company now has 1,429,417 performance rights on issue, which modestly adjusts its potential future share-based obligations and may marginally affect dilution metrics for existing shareholders.

More about EBOS Group Limited

EBOS Group Limited is a New Zealand and Australia-based company operating across the healthcare and related sectors. It is listed on both the NZX and ASX under the code EBO, reflecting its role as a significant trans-Tasman player in the distribution and provision of healthcare products and services.

See more data about EBO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1